Bandingkan Harga & Kinerja Indofarma Tbk. (INAF) vs Pollux Properties Indonesia Tbk. (POLL)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofarma Tbk. dan Pollux Properties Indonesia Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Pollux Properties Indonesia Tbk. diperdagangkan di Rp112 (kapitalisasi pasar 931,71 M). Perbedaan utamanya: Pollux Properties Indonesia Tbk. jauh lebih besar — sekitar 2,4× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | POLL | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 931,71 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →Tentang Pollux Properties Indonesia Tbk.
PT Pollux Properti Indonesia, Tbk (the "Company" or "Parent Company") established on Jakarta based on the Notarial Deed No. 40 dated December 16, 2014 by Ferdinandus Indra Santoso Atmajaya, S.H., M.H., as a substitute of Notary Esther Mercia Sulaiman, S.H., a notary in Jakarta.
Selengkapnya di halaman POLL →
